-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Non-Genetic Adaptation to Bruton Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukemia

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Translational and Post-translational Mechanisms
Friday, December 6, 2024, 3:35 PM-4:16 PM

Marek Mraz, MD

Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic; Department of Internal Medicine—Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

Disclosures: Mraz: Eli Lilly: Honoraria.

See more of: Translational and Post-translational Mechanisms
See more of: Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation